Indications -- Psoriasis/Chronic Inflammation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Indications -- Psoriasis/Chronic Inflammation

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (415)	5/26/2003 2:53:45 PM
From: Icebrg	Read Replies (2) of 631

Oral Pimecrolimus Peter S has posted some interesting data on oral Pimecrolimus to the Isotechnika board. It is a drug with a mode of action that is similar to ISA 247 (and cyclosporin). They are all calcineurin inhibitors. Although ISA247 and pimecrolimus are supposed not to cause any renal toxicity. Message 18974745 I have added some abstracts (there is not much available on oral P) in the following post. If these small-molecule drugs gain approval the biologics who are supposed to "take over" the psoriasis market will have to run (a lot) for their money. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next